O
DPLO

OppenheimerFunds’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

OppenheimerFunds’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.78M Sell
477,757
-531,177
-53% -$5.48M ﹤0.01% 824
2018
Q4 		$13.6M Buy
1,008,934
+47,338
+5% +$798K 0.02% 603
2018
Q3 		$18.7M Buy
961,596
+842,516
+708% +$17.9M 0.02% 600
2018
Q2 		$3.04M Sell
119,080
-2,432
-2% -$56.7K ﹤0.01% 838
2018
Q1 		$2.45M Sell
121,512
-25,058
-17% -$585K ﹤0.01% 841
2017
Q4 		$2.94M Sell
146,570
-16,688
-10% -$328K ﹤0.01% 857
2017
Q3 		$3.38M Sell
163,258
-19,326
-11% -$327K ﹤0.01% 848
2017
Q2 		$2.7M Sell
182,584
-29,359
-14% -$489K ﹤0.01% 871
2017
Q1 		$3.38M Buy
211,943
+8,859
+4% +$128K ﹤0.01% 869
2016
Q4 		$2.56M Sell
203,084
-202,296
-50% -$3.77M ﹤0.01% 889
2016
Q3 		$11.4M Sell
405,380
-419,623
-51% -$14.1M 0.01% 709
2016
Q2 		$28.9M Sell
825,003
-5,111
-0.6% -$161K 0.04% 458
2016
Q1 		$22.7M Sell
830,114
-398,493
-32% -$11.7M 0.03% 521
2015
Q4 		$42M Buy
1,228,607
+162,291
+15% +$5.06M 0.05% 368
2015
Q3 		$30.6M Buy
1,066,316
+356,355
+50% +$15.2M 0.04% 439
2015
Q2 		$31.8M Buy
709,961
+467,901
+193% +$17.6M 0.04% 467
2015
Q1 		$8.37M Buy
+242,060
New +$6.59M 0.01% 787

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's DPLO Position: Q1 2019 in Review

OppenheimerFunds reduced its DIPLOMAT PHARMACY, INC. (DPLO) stake by 53% in Q1 2019, selling an estimated $5.48M and leaving 477,757 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #824.

OppenheimerFunds first reported a position in DPLO in Q1 2015 and has held it in 17 quarters since. The position peaked at $42M in Q4 2015. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • OppenheimerFunds held 477,757 shares of DIPLOMAT PHARMACY, INC. worth $2.78M as of Q1 2019.
  • OppenheimerFunds sold 531,177 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $5.48M.
  • DIPLOMAT PHARMACY, INC. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #824 holding.
  • OppenheimerFunds first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and has held it in 17 quarters since.
  • OppenheimerFunds's DIPLOMAT PHARMACY, INC. position peaked at $42M in Q4 2015.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.